Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


BIIB

Biogen Idec to Report Second Quarter 2009 Financial Results on July 16, 2009 - 07/02 - 04:01 PM ET

UCB and Biogen Idec terminate Phase II multiple sclerosis trial - 07/01 - 01:15 PM ET

SmarTrend(R) News Watch: Acorda Therapeutics Sell Rights To Sell Fampridine Outside U.S. To Biogen Idec - 07/01 - 12:21 PM ET

Biogen Idec Continued Slide Tuesday, Set New Monthly Low - 07/01 - 09:11 AM ET

BIIB: Conference call regarding Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. @ 08:30 ET Today [delayed] - 07/01 - 06:49 AM ET

UCB and Biogen Idec discontinue Phase II clinical trial of CDP323 - 06/30 - 04:40 PM ET

Schaeffer's Options Update: Biogen Idec Inc. Targeted by a Calendar Spread - 06/29 - 02:04 PM ET

Biogen Idec (BIIB) Trend Change Alert: 4.1% Move in 6 Days - 06/29 - 10:49 AM ET

SmarTrend(R) News Watch: Biogen Confirms Brain Infection Case in Tysabri Patient, Downgraded at DB - 06/29 - 07:49 AM ET

Biogen Idec Fell Monday To Lowest Level In Over One Month - 06/23 - 08:57 AM ET

Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis - 06/22 - 08:00 AM ET

BIIB: Conference call regarding Biogen Idec to Present at the Goldman Sachs 30th Annual Healthcare Conference @ 11:00 ET Today [delayed] - 06/11 - 08:20 AM ET

Biogen Idec to Present at the Goldman Sachs Annual Healthcare Conference - 06/11 - 02:15 AM ET

Biogen Idec Discloses Preliminary Tabulation of Stockholder Vote - 06/11 - 02:13 AM ET

Biogen Idec Announces Preliminary Tabulation of Stockholder Vote by Independent Inspector of Elections - 06/09 - 04:05 PM ET

Biogen Idec to Present at the Goldman Sachs 30th Annual Healthcare Conference - 06/09 - 11:55 AM ET

Biogen Idec Reports Preliminary Results of Stockholder Vote - 06/09 - 08:56 AM ET

Biogen Idec Inc. Is Slightly Lower After The Close - 06/05 - 05:07 PM ET

Biogen Idec Announces Preliminary Results of Stockholder Vote - 06/04 - 01:54 PM ET

Biogen Idec Joins with the Global MS Community to Mark World MS Day - 05/27 - 03:00 AM ET

Page 1 of 9     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.